NSDL IPO: Currently, there are only two depositories in India, NSDL and CDSL, which keep all your accounts, demat accounts, etc., all the documents in electronic form. Now CDSL is already listed, but the question is whether NSDL will be able to perform like it. The biggest question is whether the price band is overvalued or not. How is the performance of NSDL in comparison to CDSL, how is the revenue, how is the profit, etc., how is the profit margin, etc., we will check everything.
Table of Contents
Key Features of NSDL IPO
Particulars | Details |
---|---|
Company Name | National Securities Depository Limited (NSDL) |
IPO Type | Offer For Sale (OFS), meaning the company will not receive direct funds |
Issue Size | Approx. ₹4,011.6 crore |
Shares Offered | 5.01 crore equity shares |
Book Running Lead Managers | ICICI Securities, Axis Capital, HSBC Securities, IDBI Capital, Motilal Oswal, SBI Capital Markets |
Registrar | MUFG Intime India Private Limited |
What Is NSDL and How Does It Compare to CDSL?
The oldest and largest depository in India is NSDL and hence the physical reach of NSDL is more than that of CDSL. Talking about statistics, at present there are more than 3.95 crore active demat accounts in NSDL or institutions. CDSL has 18,918 service centres, while NSDL is staffed by 65,391 Depository Participating Centres.
NSDL IPO is the first public offering of National Securities Depository Limited. NSDL is India’s first and largest electronic securities depository. Like CDSL, NSDL is a major institution facilitating access and transaction of demat accounts. India’s system-rich and value-based economic market is a big step forward for this. NSDL IPO is an Offer for Sale (OFS), as the company does not raise fresh funds on its own.
NSDL IPO Key Details at a Glance
Particulars | Details |
---|---|
Company Name | National Securities Depository Limited (NSDL) |
IPO Type | Offer for Sale (OFS) |
Issue Size | Approx. ₹4,011.6 crore |
Price Band | ₹760–₹800 per share |
Lot Size | 18 shares |
Minimum Investment | ₹13,680 |
Open/Close Dates | 30 July 2025 – 1 August 2025 |
Allotment Date | 4 August 2025 |
Listing Date | 6 August 2025 |
GMP (28 July 2025) | ₹135–₹155 |
Main Sellers | NSE, SBI, IDBI, HDFC, UBI, SUUTI |
Lead Managers | ICICI Securities, Axis Capital, HSBC, IDBI Capital, Motilal Oswal, SBI Cap |
Registrar | MUFG Intime India Pvt Ltd |
The IPO will open on the 30th. Then the IPO will close on the 1st. You will get a chance for three days. Allotment will come on the 4th, refunds and shares on the 5th and it is going to be listed on the 6th. Now let’s take a look at the price band. Have a look, it has been brought at a valuation of ₹760 to ₹800, that is, 800. The face value is ₹2. It has been brought at the valuation that people were expecting. This is a good thing. But a bundle of 18 shares has been kept.
IPO Quota Allocation: Know Your Category
QIB has been given a quota of 50%. Retail has been given 35%. HAI has been given around 15%. So if we apply, then we are going to apply in 35% i.e. small i.e. retail category. Talking about one lot, it is said that there is a lot of Rs 14,400. If you go below that, you can place 13 lots. In which your retail category will automatically be there.
Final Thoughts
Here, before applying for IPO, you need to keep one thing in mind. That this IPO is completely OFS, means the company will not get new capital. Another thing to note is that shares held by NSE, SBI, IDBI Bank, HDFC Bank, Union Bank, SUUTI or institutions will be available for sale to general investors.
Conclusion: Considering the company’s background, financial sector experience, and future, NSDL IPO can be a good option for new investors. Given GMP and financial trends, upside listing is a possibility. But be aware of your financial objectives while taking the final decision.
Disclaimer: The information provided in the accounts is for general information only and does not constitute financial, investment or credit advice. The views and recommendations expressed are based on publicly available data and expert opinions at the time of writing. The author or Market Read do not endorse any specific product or financial decision. MarketRead.in and its associates are not responsible for any loss arising from reliance on the information presented.